10-K Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0001144204-18-018611`
Period End Date	20171231
Filing Date	20180402
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	bpth-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 28 Cash Flow Statement 46 Stockholders Equity 19

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10,000.00	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10,000.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$8.85M	USD	Point-in-time
Cash	`Cash`	$9.38M	USD	Point-in-time
Cash	`Cash`	$5.96M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$1.12M	USD	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$376.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$902.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$353.00K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200,000.00	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200,000.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$7.43M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.65M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	11,339.00	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	9,564.00	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	9,564.00	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$984.00K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	11,339.00	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$708.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$94.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$330.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$654.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$614.00K	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Less accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.57M	USD	Point-in-time
Less accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.73M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$929.00K	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$769.00K	USD	Point-in-time
Total Assets	`Assets`	$8.86M	USD	Point-in-time
Total Assets	`Assets`	$12.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$69.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$52.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$969.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$739.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$12.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$791.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.05M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.91M	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.96M	USD	Point-in-time
Total Liabilities	`Liabilities`	$791.00K	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 11,339 and 9,564 shares issued and outstanding, respectively	`CommonStockValue`	$11.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 11,339 and 9,564 shares issued and outstanding, respectively	`CommonStockValue`	$10.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$47.21M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$40.36M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-32.13M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-39.16M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$8.07M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$8.24M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$9.82M	USD	Point-in-time
Total Liabilities & Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$8.86M	USD	Point-in-time
Total Liabilities & Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$12.20M	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$37.00K	USD	Annual
Revenue	`Revenues`	$13.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$5.48M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$5.47M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$3.52M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$3.01M	USD	Annual
Total operating expense	`OperatingExpenses`	$8.49M	USD	Annual
Total operating expense	`OperatingExpenses`	$9.00M	USD	Annual
Net operating loss	`OperatingIncomeLoss`	$-8.47M	USD	Annual
Net operating loss	`OperatingIncomeLoss`	$-8.97M	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.37M	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.71M	USD	Annual
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	$-440.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$12.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$9.00K	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$1.73M	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$1.94M	USD	Annual
Net loss	`NetIncomeLoss`	$-7.02M	USD	Annual
Net loss	`NetIncomeLoss`	$-6.75M	USD	Annual
Deemed dividend related to warrant conversion	`PreferredStockDividendsAndOtherAdjustments`	-	USD	Annual
Deemed dividend related to warrant conversion	`PreferredStockDividendsAndOtherAdjustments`	$1.04M	USD	Annual
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.75M	USD	Annual
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-8.06M	USD	Annual
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.73	USD	Annual
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.80	USD	Annual
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.27M	shares	Annual
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	10.08M	shares	Annual

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-7.02M	USD	Annual
Net loss	`NetIncomeLoss`	$-6.75M	USD	Annual
Amortization	`AdjustmentForAmortization`	$161.00K	USD	Annual
Amortization	`AdjustmentForAmortization`	$160.00K	USD	Annual
Depreciation	`Depreciation`	$251.00K	USD	Annual
Depreciation	`Depreciation`	$43.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$784.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$793.00K	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.37M	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.71M	USD	Annual
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	$-440.00K	USD	Annual
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$741.00K	USD	Annual
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$-184.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-549.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$723.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-146.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	-	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$12.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-12.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.15M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.96M	USD	Annual
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$538.00K	USD	Annual
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$338.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-338.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-538.00K	USD	Annual
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$3.57M	USD	Annual
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$9.01M	USD	Annual
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Net proceeds from exercise of warrants	`ProceedsFromStockOptionsExercised`	$1.52M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.01M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.08M	USD	Annual
Net increase (decrease) in cash	`CashPeriodIncreaseDecrease`	$-3.41M	USD	Annual
Net increase (decrease) in cash	`CashPeriodIncreaseDecrease`	$521.00K	USD	Annual
Cash, beginning of year	`Cash`	$8.85M	USD	Point-in-time
Cash, beginning of year	`Cash`	$9.38M	USD	Point-in-time
Cash, beginning of year	`Cash`	$5.96M	USD	Point-in-time
Cash, end of year	`Cash`	$8.85M	USD	Point-in-time
Cash, end of year	`Cash`	$9.38M	USD	Point-in-time
Cash, end of year	`Cash`	$5.96M	USD	Point-in-time
Warrants transferred to equity upon modification	`WarrantsTransferredToEquityUponModification`	-	USD	Annual
Warrants transferred to equity upon modification	`WarrantsTransferredToEquityUponModification`	$797.00K	USD	Annual
Conversion of warrant liability to equity	`DebtConversionOriginalDebtAmount1`	-	USD	Annual
Conversion of warrant liability to equity	`DebtConversionOriginalDebtAmount1`	$175.00K	USD	Annual
Capital expenditures included in accrued expense	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	Annual
Capital expenditures included in accrued expense	`CapitalExpendituresIncurredButNotYetPaid`	$247.00K	USD	Annual

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$8.07M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$8.24M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$9.82M	USD	Point-in-time
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$3.57M	USD	Annual
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$4.39M	USD	Annual
Issuance of common stock, net of fees (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	588,235.00	shares	Point-in-time
Issuance of common stock, net of fees (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	588,235.00	shares	Point-in-time
Exercise of warrants	`StockIssueDuringPeriodValueWarrantsExercised`	$1.52M	USD	Annual
Warrants transferred to equity upon modification	`AdjustmentsToAdditionalPaidInCapitalWarrantsTransferredToEquityUponModification`	$797.00K	USD	Annual
Conversion of warrant liability to equity	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$175.00K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$793.00K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$784.00K	USD	Annual
Deemed dividend related to warrant modification	`AdjustmentsToAdditionalPaidInCapitalDeemedDividend`	$-1.04M	USD	Annual
Modification of warrant exercise price	`AdjustmentsToAdditionalPaidInCapitalWarrantExercisePriceModification`	$1.04M	USD	Annual
Net loss	`NetIncomeLoss`	$-7.02M	USD	Annual
Net loss	`NetIncomeLoss`	$-6.75M	USD	Annual
Ending Balance	`StockholdersEquity`	$8.07M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$8.24M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$9.82M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.